Dr. Reckeweg R97 Galphimia glauca D6
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Galphimia glauca Source : Feuilles & inflorescences séchées | 6 D | Not calculated |
Non-medicinal ingredients
Eau pour injections, Chlorure de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 12 years ; maximum: 17 years | minimum: 1 Pulvérisateur ; maximum: 2 Pulvérisateur | minimum: 3 Tous les jours ; maximum: 5 Tous les jours |
| Adultes | minimum: 18 years | minimum: 1 Pulvérisateur ; maximum: 2 Pulvérisateur | minimum: 3 Tous les jours ; maximum: 5 Tous les jours |
| Enfants | minimum: 1 year ; maximum: 11 years | 1 Pulvérisateur | 4 Tous les jours |
Uses authorised in Canada
Homeopathic preparation/remedy/medicine.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use more than 30 days after the seal is broken. Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are pregnant or breastfeeding. Ingredient specific risk statements when required by NHPID.
Product record
- Other names
- Dr. Reckeweg R97 Nasal Spray, Dr. Reckeweg R97 Vaporisateur nasal
- Licence holder
- Bio Lonreco Inc.
- NPN or DIN-HM
- 80097317
- Status
- Active licence
- Licence date
- 27 February 2020
- Revision date
- Not provided
- Form
- Vaporisateur
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80097317
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Dr. Reckeweg R97 Galphimia glauca D6 (Bio Lonreco Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80097317-dr-reckeweg-r97-galphimia-glauca-d6, updated 27 February 2020.